Brevan Howard Capital Management »

Atea Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $47k 14k 3.35
2024-03-31 $84k 21k 4.04
2023-12-31 $78k 26k 3.05

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option (XLF)
Ishares Ftse/xinhua China 25 China Lg-cap Etf Call Option (FXI)
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf Call Option (HYG)
Industrial Select Sect Spdr Indl Call Option (XLI)
Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)
Health Care Select Secto Sbi Heathcare Call Option (XLV)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Spdr S&p Biotech Etf S&p Biotech (XBI)
KraneShares CSI China Internet ETF Csi Chi Internet Call Option (KWEB)
Energy Select Sector Spdr Energy Call Option (XLE)
Alibaba Group Holding Sponsored Ads (BABA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)

View all positions for Brevan Howard Capital Management

Top funds holding Atea Pharmaceuticals

BlackRock
BlackRock
BML Capital Management
EcoR1 Capital
Vanguard Group
Tang Capital Management
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Almitas Capital
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
Northern Trust
Charles Schwab Investment Management

View all funds holding Atea Pharmaceuticals